Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPIDAURUS: Escalated Antiplatelet Therapy in AF and ACS Patients Undergoing PCI
NCT04981041Phase 4Completed
- Sponsor
- Ludwig Maximilian University of Munich
- Start
- Dec 2021
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of prasugrel, ticagrelor in acute coronary syndrome (ACS), Atrial fibrillation (AFib), sponsored by Ludwig Maximilian University of Munich. Started Dec 2021; status: completed.
02
Drugs
prasugrelticagrelor
03
Conditions
acute coronary syndrome (ACS)Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT04981041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04981041.